iBio Inc. (IBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    iBio Inc.

    NASDAQ: IBIO · Real-Time Price · USD
    0.83
    0.02 (2.30%)
    At close: Sep 05, 2025, 3:59 PM
    0.83
    -0.78%
    After-hours: Sep 05, 2025, 06:34 PM EDT

    iBio Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 225K n/a 1.88M 2.37M
    Cost of Revenue
    		 1.25M 1.11M 216K 1.46M
    Gross Profit
    		 225K -1.11M 2.17M 909K
    Operating Income
    		 -16.63M -29.31M -29.7M -31.11M
    Interest Income
    		 363K 130K 177K 140K
    Pretax Income
    		 -15.44M -29.31M -29.51M -23.21M
    Net Income
    		 -24.91M -29.31M -51.01M -23.21M
    Selling & General & Admin
    		 11.67M 18.45M 21.75M 22.03M
    Research & Development
    		 5.18M 10.33M 9.83M 9.99M
    Other Expenses
    		 n/a 565K 13K 12K
    Operating Expenses
    		 16.86M 29.34M 31.36M 32.02M
    Interest Expense
    		 172K n/a n/a 2.45M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 16.86M 29.34M 52.07M 33.48M
    Income Tax Expense
    		 n/a n/a 701K 46K
    Shares Outstanding (Basic)
    		 3.83M 1.23M 872.1K 391.24K
    Shares Outstanding (Diluted)
    		 3.83M 1.23M 872.1K 391.24K
    EPS (Basic)
    		 -6.5 -23.94 -58.49 -60
    EPS (Diluted)
    		 -6.5 -23.94 -58.49 -60
    EBITDA
    		 -14.02M -28.12M -25.72M -18.34M
    EBIT
    		 -15.27M -29.23M -29.51M -20.76M
    Depreciation & Amortization
    		 1.25M 1.11M 3.79M 2.41M

    Add to Watchlist